Literature DB >> 11237681

AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse.

F Q Liang1, N S Dejneka, D R Cohen, N V Krasnoperova, J Lem, A M Maguire, L Dudus, K J Fisher, J Bennett.   

Abstract

Retinitis pigmentosa (RP), an inherited retinal degenerative disease causing blindness, is characterized by progressive apoptotic death of photoreceptors. Therapeutic modification of photoreceptor apoptosis may provide an effective therapy for this disorder. Ciliary neurotrophic factor (CNTF) has been shown to promote survival of a number of different neuronal cell types, including photoreceptors. The present study aimed to test whether adeno-associated virus (AAV)-mediated delivery of the gene encoding CNTF delays photoreceptor death in the rhodopsin knockout (opsin(-/-)) mouse, an animal model of RP. The vector was made to express a secretable form of CNTF in tandem with a marker GFP. Cultured 293 cells transduced with this virus expressed both CNTF and GFP. The conditioned media from such cells supported the survival of chick dorsal root ganglion neurons in the same manner as recombinant CNTF. Subretinal administration of this virus led to efficient transduction of photoreceptors as indicated by GFP fluorescence and CNTF immunostaining. Histologic examination showed significant photoreceptor preservation in the injected quadrant of the retina. This protection lasted through termination of the experiment (3 months). AAV-mediated delivery of CNTF may have implications for the treatment of human retinal degeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237681     DOI: 10.1006/mthe.2000.0252

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  37 in total

Review 1.  Prevention and therapy in hereditary retinal degenerations.

Authors:  Dorothea Besch; Eberhart Zrenner
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

Review 2.  Gene therapy for ocular diseases.

Authors:  Melissa M Liu; Jingsheng Tuo; Chi-Chao Chan
Journal:  Br J Ophthalmol       Date:  2010-08-23       Impact factor: 4.638

Review 3.  [Survival factors in the treatment of hereditary retinal degeneration].

Authors:  R Frigg; A Wenzel; C Grimm; C E Remé
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

4.  Novel AAV serotypes for improved ocular gene transfer.

Authors:  Corinna Lebherz; Albert Maguire; Waixing Tang; Jean Bennett; James M Wilson
Journal:  J Gene Med       Date:  2008-04       Impact factor: 4.565

5.  Retinal expression of Fgf2 in RCS rats with subretinal microphotodiode array.

Authors:  Vincent T Ciavatta; Moon Kim; Paul Wong; John M Nickerson; R Keith Shuler; George Y McLean; Machelle T Pardue
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

6.  Preconditioning-induced protection of photoreceptors requires activation of the signal-transducing receptor gp130 in photoreceptors.

Authors:  Yumi Ueki; Yun-Zheng Le; Srinivas Chollangi; Werner Muller; John D Ash
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

7.  Ciliary neurotrophic factor (CNTF) protects retinal cone and rod photoreceptors by suppressing excessive formation of the visual pigments.

Authors:  Songhua Li; Kota Sato; William C Gordon; Michael Sendtner; Nicolas G Bazan; Minghao Jin
Journal:  J Biol Chem       Date:  2018-08-16       Impact factor: 5.157

8.  Expression of cytokine signal transduction components in the postnatal mouse retina.

Authors:  Kun Do Rhee; Xian-Jie Yang
Journal:  Mol Vis       Date:  2003-12-16       Impact factor: 2.367

9.  Current concepts in the treatment of retinitis pigmentosa.

Authors:  Maria A Musarella; Ian M Macdonald
Journal:  J Ophthalmol       Date:  2010-10-11       Impact factor: 1.909

10.  Effects of calcium ion, calpains, and calcium channel blockers on retinitis pigmentosa.

Authors:  Mitsuru Nakazawa
Journal:  J Ophthalmol       Date:  2010-12-23       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.